COVID-19: Special Populations and Risk Factors
This special issue belongs to the section "Infectious Diseases".
Special Issue Information
Dear Colleagues,
Since December 2019, severe acute coronavirus syndrome 2 (SARS-CoV-2), responsible for COVID-19, has spread from Wuhan City (China) to other parts of the world. By 7 January 2021, 87.7 million cases had been diagnosed, leading to at least 1.8 million deaths. In this current pandemic, special populations at a high risk of adverse outcome have been identified.
For this Special Issue, we invite researchers to contribute with articles describing the clinical features of the disease as well as the prognostic factors in special populations, such as very old patients, immunosuppressed patients, transplantation, health professional, nursing home residents, neoplasms and so on. We welcome papers addressing the relationship between risk factors of adverse outcome (fatality, complications, poor prognosis, acute severe respiratory distress, or acute respiratory failure) in special population and conditions affected by SARS-Cov2. We would appreciate research (original articles and reviews) examining the relation of adverse outcomes in special populations hospitalized with COVID-19
Dr. Jose-Manuel Ramos-Rincon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19
- SARS-CoV-2
- hospitalized patients
- special population
- very old patients
- long term care resident
- younger people
- health professional
- immunosuppression
- immunosuppressed patients
- transplantation
- autoimmune diseases
- diabetes mellitus
- hypertension
- heart failure
- neoplasms
- epidemiology
- risk factors
- mortality
- poor outcome
- adverse outcome
- causes of mortality
- severity of COVID-19
- acute severe respiratory distress
- acute respiratory failure
- readmission
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
J. Clin. Med. - ISSN 2077-0383